Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

Falagas, 2008, Acinetobacter infections: a growing threat for critically ill patients, Epidemiol Infect, 136, 1009, 10.1017/S0950268807009478 Falagas, 2008, Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opin Investig Drugs, 17, 973, 10.1517/13543784.17.7.973 Levin, 1999, Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, Clin Infect Dis, 28, 1008, 10.1086/514732 Garnacho-Montero, 2003, Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP, Clin Infect Dis, 36, 1111, 10.1086/374337 Michalopoulos, 2005, Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic, Clin Microbiol Infect, 11, 115, 10.1111/j.1469-0691.2004.01043.x Kasiakou, 2005, Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis, Antimicrob Agents Chemother, 49, 3136, 10.1128/AAC.49.8.3136-3146.2005 Falagas, 2006, Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin–meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections, Clin Microbiol Infect, 12, 1227, 10.1111/j.1469-0691.2006.01559.x Kallel, 2007, Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case–control study, Intensive Care Med, 33, 1162, 10.1007/s00134-007-0675-2 Rios, 2007, Ventilator-associated pneumonia due to colistin susceptible-only microorganisms, Eur Respir J, 30, 307, 10.1183/09031936.00156906 Lee, 2008, Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia, Microb Drug Resist, 14, 233, 10.1089/mdr.2008.0840 Rynn, 1999, In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics, Clin Microbiol Infect, 5, 32, 10.1111/j.1469-0691.1999.tb00095.x Yoon, 2004, In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii, Antimicrob Agents Chemother, 48, 753, 10.1128/AAC.48.3.753-757.2004 Hawley, 2008, Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy, Antimicrob Agents Chemother, 52, 351, 10.1128/AAC.00766-07 Tan, 2007, Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model, Antimicrob Agents Chemother, 51, 3413, 10.1128/AAC.01571-06 Bliziotis, 2005, Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials, Clin Infect Dis, 41, 149, 10.1086/430912